Skip to main content
Chison Medical Technologies Co.,Ltd. logo

Chison Medical Technologies Co.,Ltd. — Investor Relations & Filings

Ticker · 688358 ISIN · CNE1000076R4 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 686 across all filing types
Latest filing 2022-04-19 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 688358

About Chison Medical Technologies Co.,Ltd.

https://www.chison.com/

Chison Medical Technologies Co.,Ltd. specializes in the research, development, and manufacturing of diagnostic ultrasound systems. The company offers a comprehensive portfolio of medical imaging solutions, including trolley-based color Doppler systems, portable ultrasound units, and specialized handheld devices. Its products integrate advanced imaging technologies such as 4D imaging, artificial intelligence-assisted diagnostics, and high-resolution transducers to support clinical applications in cardiology, obstetrics, gynecology, and point-of-care settings. Chison focuses on delivering high-performance diagnostic tools to healthcare providers, supported by a global network of research centers and distribution channels. The company emphasizes continuous innovation in digital signal processing and transducer technology to enhance diagnostic accuracy and clinical workflow efficiency.

Recent filings

Filing Released Lang Actions
国金证券股份有限公司关于祥生医疗2021年度持续督导跟踪报告
Audit Report / Information Classification · 95% confidence The document is titled as a "2021年度持续督导跟踪报告" (2021 Annual Continuous Supervision Follow-up Report) issued by Guojin Securities Co., Ltd. as the sponsor institution for Wuxi Xiangsheng Medical Technology Co., Ltd. It references regulatory frameworks related to securities issuance and listing supervision, and details the continuous supervision activities, risk factors, financial data, and compliance with fundraising usage. The document contains substantive financial data, risk disclosures, and detailed supervisory activities rather than just an announcement or certification. It is a report related to ongoing sponsor supervision after the company's listing, which aligns with the definition of an Audit Report / Information (AR) as it is a standalone supervisory report by the sponsor, not a full annual report (10-K) or earnings release. The length (over 11,000 characters) and detailed content confirm it is a full report, not a mere announcement. Therefore, the appropriate classification is AR (Audit Report / Information). FY 2021
2022-04-19 Chinese
容诚会计师事务所（特殊普通合伙）关于无锡祥生医疗科技股份有限公司内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It is issued by a certified public accounting firm and references auditing standards and responsibilities related to internal control over financial reporting as of December 31, 2021. The document includes an audit opinion on the effectiveness of internal controls, which is typical of an audit report rather than a full annual report or interim report. The document length is 2566 characters, which is relatively short but contains substantive audit content, not just an announcement or certification. Therefore, it fits the category of an Audit Report / Information (AR). FY 2021
2022-04-18 Chinese
关于无锡祥生医疗科技股份有限公司非经营性资金占用及其他关联资金往来情况汇总表的专项审计报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report issued by an accounting firm (RSM 容诚会计师事务所) regarding non-operating fund occupation and related party fund transactions for Wuxi Xiangsheng Medical Technology Co., Ltd. for the fiscal year 2021. It includes detailed tables summarizing these transactions and references compliance with Chinese securities regulatory requirements. The document contains an auditor's opinion and detailed financial data related to the audit of these specific transactions, separate from the full annual financial statements. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles related to specific issues, excluding full annual reports. The document is over 13,000 characters, indicating it is a full report, not just an announcement. Therefore, the correct classification is AR with high confidence. FY 2021
2022-04-18 Chinese
无锡祥生医疗科技股份有限公司2021年年度报告
Annual Report Classification · 100% confidence The document is titled '2021 年年度报告' which translates to '2021 Annual Report'. It is issued by 无锡祥生医疗科技股份有限公司 (Wuxi Chison Medical Technologies Co., Ltd.). The document contains detailed sections typical of an annual report, including company overview, financial data, management discussion and analysis, corporate governance, social responsibility, and audited financial statements. It includes comprehensive financial figures for the year 2021, quarterly breakdowns, and detailed management commentary. The length of the document (15,000 characters) and the presence of substantive financial data and analysis confirm it is the full annual report rather than an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2021
2022-04-18 Chinese
祥生医疗关于召开2021年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2021 Annual General Meeting (AGM) of Wuxi Xiangsheng Medical Technology Co., Ltd. It includes details such as the date, location, voting methods, agenda items to be discussed, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather the announcement and logistical information for the AGM. The document length is 3559 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2022-04-18 Chinese
无锡祥生医疗科技股份有限公司2022年第一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled '2022年第一季度报告' which translates to '2022 First Quarter Report'. It contains detailed financial data including income statements, balance sheets, cash flow statements, and notes on financial performance for the first quarter of 2022. The report explicitly states it is unaudited and covers a period shorter than a full fiscal year (quarterly). The presence of comprehensive financial statements and analysis confirms it is an Interim / Quarterly Report. The document length is about 15,000 characters, indicating it is the full report, not just an announcement or certification. Therefore, the appropriate classification is 'IR' for Interim / Quarterly Report. Q1 2022
2022-04-18 Chinese

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.